# Ligand Pharmaceuticals Incorporated (LGND): MoatMap facts

As of 24 Oct 2026. Research data, not investment advice.

As of 24 Oct 2026, MoatMap's StockRank for Ligand Pharmaceuticals Incorporated (LGND) is 71/100, ranked against 24,000+ stocks in 35 markets (Quality 64, Value 23, Momentum 79, each scored against its sector).

- StockRank: 71/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 64, Value 23, Momentum 79: each a 0-100 percentile within Healthcare.
- Position: #7,892 overall, #812 in Healthcare.
- Listing: United States, NGM; Healthcare / Biotechnology.
- Last close: 303.53 USD on 23 Oct 2026.
- Insider filings, last 180 days: directors sold USD 25.1M.
- Buybacks, last 180 days: the company bought back USD 60.0M on 1 day.

Source: https://moatmap.ai/stock/LGND
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker